A Case of Severe Human Granulocytic Anaplasmosis in an Immunocompromised Pregnant Patient

Marijo Aguilera, Anne Marie Furuseth, Lauren Giacobbe, Katherine Jacobs, Kirk Ramin

Abstract


Human granulocytic anaplasmosis (HGA) is a tick-borne disease that can often result in persistent fevers and other non-specific symptoms including myalgias, headache, and malaise. The incidence among endemic areas has been increasing, and clinician recognition of disease symptoms has aided in the correct diagnosis and treatment of patients who have been exposed. While there have been few cases reported of HGA disease during pregnancy, all patients have undergone a relatively mild disease course without complications. HGA may cause more severe disease in the elderly and immunocompromised. Herein, we report an unusual presentation and severe disease complications of HGA in a pregnant female who was concomitantly immunocompromised due to azathioprine treatment of her Crohn’s disease. Following successful treatment with rifampin, she subsequently delivered a healthy female infant without any disease sequelae.




J Med Cases. 2015;6(6):282-284
doi: http://dx.doi.org/10.14740/jmc811w

Keywords


Anaplasma; Ehrlichiosis; Tick-borne disease pregnancy; Rifampin

Full Text: HTML PDF
 

Browse  Journals

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.